Myrna Weissman, PhD
Diane Goldman Kemper Family Professor of Epidemiology (in Psychiatry)
Dr. Weissman is a Professor of Epidemiology and Psychiatry, College of Physicians and Surgeons and the School of Public Health at Columbia University and Chief of the Department in Clinical-Genetic Epidemiology at New York State Psychiatric institute. Until 1987, she was a Professor of Psychiatry and Epidemiology at Yale University School of Medicine and Director of the Depression Research Unit. She was a Visiting Senior Scholar (1979-1980) at the Institute of Medicine, National Academy of Sciences, Washington, D.C. In 1974, she received a Ph.D. in chronic disease epidemiology from Yale University. Her current research is on epidemiology, detection, treatment; and the genetics of affective and anxiety disorders.
Dr. Weissman has been a consultant to many private and public agencies, including the World Health Organization, the White House Office of Science and Technology Policy, the John D. and Catherine T. MacArthur Foundation, and the Institute of Medicine, National Academy of Science. She has been the author or a co-author of over 550 scientific articles and chapters, and 11 books, including Interpersonal Psychotherapy of Depression, Basic Books, New York, 1984, with her late husband, Gerald L. Klerman, Bruce J. Rounsaville, and Eve S. Chevron; A Comprehensive Guide to Interpersonal Psychotherapy, Basic Books, New York, 2000 with Gerald L. Klerman and John Markowitz; and Treatment of Depression: Bridging the 21st Century, API Press, 2001 and Weissman, a Clinician's Quick Guide to Interpersonal Psychotherapy, Oxford University Press, New York, NY: 2007.
The Genetics of Epidemiology and Treatment of Mood and Anxiety Disorder
1) A 3-generation longitudinal study of families at high- and low-risk for depression, including MRI and genetic studies. 2) A genetic study of early onset recurrent depression. 3) A study examining the efforts of parental remission from depression on offspring psychopathology. 4) Studies of psychiatric disorders in primary care and efforts to provide evidenced-based economic treatment.